Prognostic value of a mitochondrial functional score in prostate cancer

Journal of International Medical Research

Volumn 40, Issue 1, 2012, Pages 371-376

  Sun, X ^a   Liao, N K ^b   Yu, Jian Jun ^b  

^a First People's Hospital of Kunming   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Gleason score; Mitochondrial functional score; Prostate cancer

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER GRADING; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSTIC VALUE; GLEASON SCORE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MITOCHONDRIAL FUNCTIONAL SCORE; PREDICTION; PROSTATE CANCER; PROSTATECTOMY; RETROSPECTIVE STUDY; SCORING SYSTEM;

EID: 84863245894     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001204000139     Document Type: Article

References (31)

1. Naitoh J, Zeiner RL, Dekernion JB: Diagnosis and treatment of prostate cancer. Am Fam Physician 1998; 57: 1531-1539.
2. Siegel R, Ward E, Brawley O, et al: Cancer statistics, 2011. CA Cancer J Clin 2011; 61: 212-236.
3. Helpap B, Egevad L: The significance of modified Gleason grading of prostatic carcinoma in biopsy and radical prostatectomy specimens. Virchows Arch 2006; 449: 622-627.
4. Walsh PC: Chemoprevention of prostate cancer. N Engl J Med 2010; 362: 1237-1238.
5. Lueth M, Wronski L, Giese A, et al: Somatic mitochondrial mutations in pilocytic astrocytoma. Cancer Genet Cytogenet 2009; 192: 30-35.
6. Kassauei K, Habbe N, Mullendore ME, et al: Mitochondrial DNA mutations in pancreatic cancer. Int J Gastrointest Cancer 2006; 37: 57-64.
7. Ishikawa K, Takenaga K, Akimoto M, et al: ROSgenerating mitochondrial DNA mutations can regulate tumor cell metastasis. Science 2008; 320: 661-664.
8. Modica-Napolitano JS, Singh KK: Mitochondrial dysfunction in cancer. Mitochondrion 2004; 4: 755-762.
9. Stamey TA, McNeal JE, Freiha FS, et al: Morphometric and clinical studies on 68 consecutive radical prostatectomies. J Urol 1988; 139: 1235-1241.
10. Helpap B, Egevad L: Correlation of modified Gleason grading with pT stage of prostatic carcinoma after radical prostatectomy. Anal Quant Cytol Histol 2008; 30: 1-7.
11. Flameng W, Borgers M, Daenen W, et al: Ultrastructural and cytochemical correlates of myocardial protection by cardiac hypothermia in man. J Thorac Cardiovasc Surg 1980; 79: 413-424.
12. Oon SF, Pennington JM, Fitzpatrick R, et al: Biomarker research in prostate cancer-towards utility, not futility. Nat Rev Urol 2011; 8: 131-138.
13. McBride HM, Neuspiel M, Wasiak S: Mitochondria: more than just a powerhouse. Curr Biol 2006; 16: R551-R560.
14. Campello S, Lacalle RA, Bettella M, et al: Orchestration of lymphocyte chemotaxis by mitochondrial dynamics. J Exp Med 2006; 203: 2879-2886.
15. Arnold RS, Sun CQ, Richards JC, et al: Mitochondrial DNA mutation stimulates prostate cancer growth in bone stromal environment. Prostate 2009; 69: 1-11.
16. Petros JA, Baumann AK, Ruiz-Pesini E, et al: mtDNA mutations increase tumorigenicity in prostate cancer. Proc Natl Acad Sci USA 2005; 102: 719-724.
17. Kuznetsov AV, Hermann M, Saks V, et al: The cell-type specificity of mitochondrial dynamics. Int J Biochem Cell Biol 2009; 41: 1928-1939.
18. Carew JS, Huang P: Mitochondrial defects in cancer. Mol Cancer 2002; 1: 9-11.
19. Taylor RW, Turnbull DM: Mitochondrial DNA mutations in human disease. Nat Rev Genet 2005; 6: 389-402.
20. Higuchi M: Regulation of mitochondrial DNA content and cancer. Mitochondrion 2007; 7: 53-57.
21. Knott AB, Perkins G, Schwarzenbacher R, et al: Mitochondrial fragmentation in neuro-degeneration. Nat Rev Neurosci 2008; 9: 505-518.
22. Arnheim N, Cortopassi G: Deleterious mitochondrial DNA mutations accumulate in aging human tissues. Mutat Res 1992; 275: 157-167.
23. 0-ATP synthases. Int Rev Cell Mol Biol 2008; 267: 1-58.
24. Singh KK, Kulawiec M, Still I, et al: Intergenomic cross talk between mitochondria and the nucleus plays an important role in tumorigenesis. Gene 2005; 354: 140-146.
25. Takahashi Y, Iida K, Takeno R, et al: Hepatic failure and enhanced oxidative stress in mitochondrial diabetes. Endocr J 2008; 55: 509-514.
26. Benard G, Rossignol R: Ultrastructure of the mitochondrion and its bearing on function and bioenergetics. Antioxid Redox Signal 2008; 10: 1313-1342.
27. Poulton J, Marchington DR: Segregation of mitochondrial DNA (mtDNA) in human oocytes and in animal models of mtDNA disease: clinical implications. Reproduction 2002; 123: 751-755.
28. Singh KK, Russell J, Sigala B, et al: Mitochondrial DNA determines the cellular response to cancer therapeutic agents. Oncogene 1999; 18: 6641-6646.
29. Shidara Y, Yamagata K, Kanamori T, et al: Positive contribution of pathogenic mutations in the mitochondrial genome to the promotion of cancer by prevention from apoptosis. Cancer Res 2005; 65: 1655-1663.
30. Nakagawa T, Shimizu S, Watanabe T, et al: Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 2005; 434: 652-658.
31. McKenzie D, Bua E, McKiernan S, et al: Mitochondrial DNA deletion mutations: A causal role in sarcopenia. Eur J Biochem 2002; 269: 2010-2015.